InMode (INMD) Income from Non-Controlling Interests (2018 - 2021)
InMode (INMD) posted Income from Non-Controlling Interests of $206000.0 for Q4 2021, up 300.0% sequentially from -$103000.0 in Q1 2021, and up 368.18% YoY from $44000.0 in Q4 2020.
InMode (INMD) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends
InMode has reported Income from Non-Controlling Interests for 4 years, with the latest figure at $206000.0 in Q4 2021.
- Quarterly Income from Non-Controlling Interests rose 368.18% year-over-year to $206000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $103000.0 (up 1960.0% YoY) and the FY2021 annual result came in at $103000.0, up 2160.0% from the prior year.
- Income from Non-Controlling Interests climbed to $206000.0 in Q4 2021 per INMD's latest filing, from -$103000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $206000.0 in Q4 2021 and troughed at -$103000.0 in Q1 2021.
- A 4-year average of $14272.7 and a median of $8000.0 in 2020 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2019 and 2020: Income from Non-Controlling Interests surged 1200.0% in 2019, then sank 270.59% in 2020.
- Over 4 years, Income from Non-Controlling Interests stood at -$6000.0 in 2018, then soared by 1200.0% to $66000.0 in 2019, then plunged by 33.33% to $44000.0 in 2020, then jumped by 368.18% to $206000.0 in 2021.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $206000.0, -$103000.0, and $44000.0 for Q4 2021, Q1 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 900,000.00 |
| 10 | InMode | 921.69 Mn | 506.52 Mn | 71.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 206,000.00 |
| Mar 31, 2021 | -103,000.00 |
| Dec 31, 2020 | 44,000.00 |
| Sep 30, 2020 | 11,000.00 |
| Jun 30, 2020 | 8,000.00 |
| Mar 31, 2020 | -58,000.00 |
| Dec 31, 2019 | 66,000.00 |
| Sep 30, 2019 | -7,000.00 |
| Jun 30, 2019 | -38,000.00 |
| Mar 31, 2019 | 34,000.00 |
| Dec 31, 2018 | -6,000.00 |